In this episode, we welcome Enrique Arevalo, co-founder and CEO of Spectrus, a biotech company specializing in mass spectrometry solutions.  Enrique shares his journey from studying chemistry and biochemistry to launching Spectrus, which uses cutting-edge technology to help biotech companies analyze molecules in the drug development process. He breaks down how mass spectrometry works and how AI and bioinformatics are transforming data analysis by enabling researchers to decode proteins and improve drug development. Enrique also discusses the importance of automation, staying ahead of industry advancements, and managing unnecessary spending. Join us for a fascinating conversation on how Spectrus is revolutionizing biotech research through innovation.